BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 2177799)

  • 1. [Treatment of infectious diseases due to methicillin-resistant Staphylococcus aureus (MRSA)].
    Kanno H
    Nihon Rinsho; 1990 Oct; 48(10):2355-64. PubMed ID: 2177799
    [No Abstract]   [Full Text] [Related]  

  • 2. [The Dutch MRSA policy should be retained].
    Vlaminckx BJ; Troelstra A; van der Bruggen T
    Ned Tijdschr Geneeskd; 2006 Aug; 150(34):1884. PubMed ID: 16970011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diminished vancomycin and daptomycin susceptibility during prolonged bacteremia with methicillin-resistant Staphylococcus aureus.
    Bennett JW; Murray CK; Holmes RL; Patterson JE; Jorgensen JH
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):437-40. PubMed ID: 18096352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No mercy for MRSA: treatment alternatives to vancomycin and linezolid.
    Wegner DL
    MLO Med Lab Obs; 2005 Jan; 37(1):26-9. PubMed ID: 15743145
    [No Abstract]   [Full Text] [Related]  

  • 5. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
    Sakoulas G; Moellering RC
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S360-7. PubMed ID: 18462091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Methicillin-resistant Staphylococcus aureus (MRSA) -- therapy and hygienic measures].
    Linde H; Lehn N
    Dtsch Med Wochenschr; 2005 Mar; 130(11):586-8; quiz 589-92. PubMed ID: 15761788
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical epidemiology of an outbreak of nosocomial infections by Staphylococcus aureus resistant to methicillin and aminoglucosides: efficacy of the measures of control].
    Parras F; Coello R
    Med Clin (Barc); 1993 Sep; 101(9):359. PubMed ID: 8412405
    [No Abstract]   [Full Text] [Related]  

  • 8. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
    Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR
    N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [What is certain in the topical eradication of MRSA from carriers?].
    Dziekan G; Mlangeni D; Daschner FD
    Dtsch Med Wochenschr; 2001 Jun; 126(25-26):761-3. PubMed ID: 11455670
    [No Abstract]   [Full Text] [Related]  

  • 10. Nosocomial methicillin--resistant Staphylococcus aureus with reduced susceptibility to vancomycin.
    Bhat G; Kamath S; Hussain A
    Indian J Pathol Microbiol; 2006 Apr; 49(2):311-2. PubMed ID: 16933753
    [No Abstract]   [Full Text] [Related]  

  • 11. Staphylococcus aureus: methicillin-susceptible S. aureus to methicillin-resistant S. aureus and vancomycin-resistant S. aureus.
    Rehm SJ; Tice A
    Clin Infect Dis; 2010 Sep; 51 Suppl 2():S176-82. PubMed ID: 20731575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
    Micek ST
    Clin Infect Dis; 2007 Sep; 45 Suppl 3():S184-90. PubMed ID: 17712745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The killer bug.
    Shnayerson M
    Fortune; 2002 Sep; 146(6):149-50, 152, 154 passim. PubMed ID: 12360834
    [No Abstract]   [Full Text] [Related]  

  • 14. [Determination of the in vitro activity of 2 glycopeptides (vancomycin and teicoplanin) against methicillin-resistant Staphylococcus aureus of intrahospital origin].
    Gil M; Otth L; Wilson M; Arce E; Zaror A; Lizama V
    Rev Med Chil; 2000 Jan; 128(1):111-2. PubMed ID: 10883531
    [No Abstract]   [Full Text] [Related]  

  • 15. Costs of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and its control.
    Gould IM
    Int J Antimicrob Agents; 2006 Nov; 28(5):379-84. PubMed ID: 17045462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methicillin resistant Staphylococcus aureus: where are we now?
    Allen DM
    Singapore Med J; 1991 Feb; 32(1):17-9. PubMed ID: 2017696
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus.
    Charles PG; Ward PB; Johnson PD; Howden BP; Grayson ML
    Clin Infect Dis; 2004 Feb; 38(3):448-51. PubMed ID: 14727222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Basic and clinical knowledge of methicillin resistant Staphylococcus aureus].
    Hayashi K
    Nihon Seikeigeka Gakkai Zasshi; 1993 Jul; 67(7):684-91. PubMed ID: 8409638
    [No Abstract]   [Full Text] [Related]  

  • 19. [The reduction of methicillin resistance in Streptococcus aureus in a hospital environment in Sousse (Tunisia)].
    Mzoughi R; Gouiaa R; Jeddi M
    Bull Soc Pathol Exot; 1994; 87(2):89-90. PubMed ID: 8061534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nosocomial methicillin-resistant staphylococci that remain sensitive to non-beta lactam antibiotics].
    Manfredi R; Nanetti A; Morelli S; Valentini R; Ferri M; Calza L; Chiodo F
    Recenti Prog Med; 2003; 94(7-8):344. PubMed ID: 12868245
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.